Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12

REED, L. J., & Muench, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 20,341 · see citing works

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.

de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858 · see citing works

Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization

Lieschke, G. J., Grail, D., HODGSON, G. S., Metcalf, D., Stanley, E. G., Cheers, C., Fowler, K., Basu, S., Zhan, Y., & Dunn, A. (1994) · Blood · doi:10.1182/blood.v84.6.1737.1737 · Cited by 956 · see citing works

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.

Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934 · see citing works

A simple method of estimating fifty per cent end-points.

Reed, L. (1938) · Medical Entomology and Zoology · Cited by 925 · see citing works

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Cheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889 · see citing works

Cyclooxygenase‐independent actions of cyclooxygenase inhibitors

Tegeder, I., Pfeilschifter, J. M., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 748 · see citing works

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 728 · see citing works

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725 · see citing works

Influenza vaccine: The challenge of antigenic drift

Carrat, F., & Flahault, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.027 · Cited by 711 · see citing works

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3

Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677 · see citing works

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 613 · see citing works

Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus

Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551 · see citing works

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

McAuley, J. L., Hornung, F., Boyd, K. L., Smith, A. M., McKeon, R., Bennink, J., Yewdell, J. W., & McCullers, J. A. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.001 · Cited by 389 · see citing works

Cyclooxygenase knockout mice

Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230 · see citing works

Cyclooxygenases and prostaglandins: shaping up the immune response

Rocca, B., & FitzGerald, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00204-1 · Cited by 219 · see citing works

Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors

Oka, T., Oka, K., Kobayashi, T., Sugimoto, Y., Ichikawa, A., Ushikubi, F., Narumiya, S., & Saper, C. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.048140 · Cited by 189 · see citing works

Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis

Saitō, H., Sherwood, E. R., Varma, T. K., & Evers, B. M. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.08.002 · Cited by 173 · see citing works

“Emergency” granulopoiesis in G-CSF–deficient mice in response to Candida albicans infection

Basu, S., HODGSON, G. S., Zhang, H., Katz, M., Quilici, C., & Dunn, A. R. (2000) · Blood · doi:10.1182/blood.v95.12.3725 · Cited by 144 · see citing works

Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice.

Zhan, Y., Lieschke, G., Grail, D., Dunn, A., & Cheers, C. (1998) · Blood · doi:10.1182/blood.v91.3.863 · Cited by 141 · see citing works

Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development

Rocca, B., Spain, L. M., Puré, E., Langenbach, R. J., Patrono, C., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6400 · Cited by 133 · see citing works

Microinjection of a cyclooxygenase inhibitor into the anteroventral preoptic region attenuates LPS fever

Scammell, T. E., Griffin, J. D., Elmquist, J. K., & Saper, C. B. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r783 · Cited by 130 · see citing works

Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection

Carey, M. A., Bradbury, J. A., Seubert, J. M., Langenbach, R. J., Zeldin, D. C., & Germolec, D. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6878 · Cited by 121 · see citing works

Hypothermia in systemic inflammation: role of cytokines

Lisa, R. (2004) · Frontiers in bioscience · doi:10.2741/1381 · Cited by 117 · see citing works

Selective Cyclooxygenase-1 and -2 Inhibitors Each Increase Allergic Inflammation and Airway Hyperresponsiveness in Mice

Peebles, R. S., Hashimoto, K., Morrow, J. D., Dworski, R., Collins, R. D., Hashimoto, Y., Christman, J. W., Kang, K.-H., Jarzecka, K., Furlong, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.8.2106025 · Cited by 116 · see citing works

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy

Schönthal, A. H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604049 · Cited by 104 · see citing works

Specific roles of cyclooxygenase‐1 and cyclooxygenase‐2 in lipopolysaccharide‐induced fever and fos expression in rat brain

Zhang, Y., Lu, J., Elmquist, J. K., & Saper, C. B. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10743 · Cited by 102 · see citing works

Confronting an influenza pandemic with inexpensive generic agents: can it be done?

Fedson, D. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70070-7 · Cited by 94 · see citing works

Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might work

Fedson, D. S. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00090.x · Cited by 93 · see citing works

Thermoregulatory Actions of Eicosanoids in the Central Nervous System with Particular Regard to the Pathogenesis of Fever

Milton, A. S. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22625.x · Cited by 85 · see citing works

Infrared body temperature measurement of mice as an early predictor of death in experimental fungal infections

Warn, P. A., Brampton, M. W., Sharp, J., Morrissey, G., Steel, N., Denning, D. W., & Priest, T. (2003) · Laboratory Animals · doi:10.1258/00236770360563769 · Cited by 78 · see citing works

Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection

Gregory, A. D., Hogue, L. A., Ferkol, T. W., & Link, D. C. (2006) · Blood · doi:10.1182/blood-2005-01-015081 · Cited by 76 · see citing works

Influenza virus antigenic variation, host antibody production and new approach to control epidemics

Chen, J., & Deng, Y. (2009) · Virology Journal · doi:10.1186/1743-422x-6-30 · Cited by 71 · see citing works

Cyclooxygenase enzymes in allergic inflammation and asthma

Carey, M. A., Germolec, D. R., Langenbach, R. I., & Zeldin, D. C. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00076-0 · Cited by 69 · see citing works

Accentuated T Helper Type 2 Airway Response after Allergen Challenge in Cyclooxygenase-1−/− but Not Cyclooxygenase-2−/− Mice

Carey, M. A., Germolec, D. R., Bradbury, J. A., Gooch, R. A., Moorman, M. P., Flake, G. P., Langenbach, R. J., & Zeldin, D. C. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200211-1383oc · Cited by 64 · see citing works

Cyclooxygenase-1 or -2—which one mediates lipopolysaccharide-induced hypothermia?

Steiner, A. A., Hunter, J. C., Phipps, S. M., Nucci, T. B., de Oliveira, D. L., Roberts, J., Scheck, A. C., Simmons, D. L., & Romanovsky, A. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.91026.2008 · Cited by 58 · see citing works

Escherichia coli lipopolysaccharides produce serotype-specific hypothermic response in biotelemetered rats

Akarsu, E. S., & Mamuk, S. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00786.2006 · Cited by 48 · see citing works

Development of a murine hypothermia model for study of respiratory tract influenza virus infection.

Wong, J. P., Saravolac, E. G., Clement, J. G., & Nagata, L. P. (1997) · PubMed · Cited by 43 · see citing works

Influenza (“Bird Flu”), inflammation and anti-inflammatory/analgesic drugs

Rainsford, K. D. (2006) · Inflammopharmacology · doi:10.1007/s10787-006-0002-5 · Cited by 37 · see citing works

The resurgence of swine-origin influenza A (H1N1)

Mossad, S. B. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.09047 · Cited by 32 · see citing works

COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice

Narko, K., Zweifel, B. S., Trifan, O. C., Ristimaki, A. P., Lane, T. F., & Hla, T. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.01.002 · Cited by 25 · see citing works

Interferon type I receptor-deficient mice have altered disease symptoms in response to influenza virus

Traynor, T. R., Majde, J. A., Bohnet, S. G., & Krueger, J. M. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.09.007 · Cited by 21 · see citing works

Into the Eye of the Cytokine Storm

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works

The cytokine storm of severe influenza and development of immunomodulatory therapy

Liu, Q., Zhou, Y., & Yang, Z. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 714 · see citing works

COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation

Zabetakis, I., Lordan, R., Norton, C., & Τσούπρας, Α. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 535 · see citing works

Targeting the “Cytokine Storm” for Therapeutic Benefit

D’Elia, R. V., Harrison, K., Oyston, P. C. F., Lukaszewski, R. A., & Clark, G. C. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00636-12 · Cited by 322 · see citing works

Immunomodulatory therapy for severe influenza

Darwish, I., Mubareka, S., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.56 · Cited by 128 · see citing works

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy

Pizzorno, A., Padey, B., Terrier, O., & Rosa-Calatrava, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00531 · Cited by 122 · see citing works

Animal Models for Influenza Viruses: Implications for Universal Vaccine Development

Margine, I., & Krammer, F. (2014) · Pathogens · doi:10.3390/pathogens3040845 · Cited by 111 · see citing works

The role of adjuvant immunomodulatory agents for treatment of severe influenza

Hui, D. S. C., Lee, N. L. S., Chan, P. K. S., & Beigel, J. H. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.01.002 · Cited by 113 · see citing works

The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment

van Vuren, E. J., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111200 · Cited by 105 · see citing works

Treating Influenza Infection, From Now and Into the Future

Davidson, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01946 · Cited by 94 · see citing works

The roles of lipids in SARS-CoV-2 viral replication and the host immune response

Theken, K. N., Tang, S. Y., Sengupta, S., & FitzGerald, G. A. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100129 · Cited by 89 · see citing works

Lariciresinol-4-O-β-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response

Li, J., Zhou, B., Li, C., Chen, Q., Wang, Y., Li, Z., Chen, T., Yang, C., Jiang, Z., Zhong, N., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.08.037 · Cited by 85 · see citing works

Emerging cellular targets for influenza antiviral agents

Müller, K. H., Kakkola, L., Nagaraj, A. S., Cheltsov, A. V., Anastasina, M., & Kainov, D. E. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.10.004 · Cited by 85 · see citing works

The amazing innate immune response to influenza A virus infection

Tripathi, S., White, M. R., & Hartshorn, K. L. (2013) · Innate Immunity · doi:10.1177/1753425913508992 · Cited by 85 · see citing works

Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents

Perico, N., Cortinovis, M., Suter, F., & Remuzzi, G. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00433-9 · Cited by 80 · see citing works

Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway

Liang, X., Huang, Y., Pan, X., Hao, Y., Chen, X., Jiang, H., Li, J., Zhou, B., & Yang, Z. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2019.09.005 · Cited by 75 · see citing works

The Role of Cytokine Responses During Influenza Virus Pathogenesis and Potential Therapeutic Options

Teijaro, J. R. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_411 · Cited by 68 · see citing works

COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies

Bağhaki, S., Yalçın, C. E., Baghaki, H. S., Aydın, S. Y., Dağhan, B., & Yavuz, E. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1466 · Cited by 69 · see citing works

Newer influenza antivirals, biotherapeutics and combinations

Hayden, F. G. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12045 · Cited by 67 · see citing works

Role of Alveolar Macrophages in the Inflammatory Response After Trauma

Niesler, U., Palmer, A., Radermacher, P., & Huber-Lang, M. S. (2014) · Shock · doi:10.1097/shk.0000000000000167 · Cited by 65 · see citing works

Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2

Hegde, P., Maddur, M. S., Friboulet, A., Bayry, J., & Kaveri, S. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026312 · Cited by 65 · see citing works

The Prostanoid 15-Deoxy-Δ12,14-Prostaglandin-J2 Reduces Lung Inflammation and Protects Mice Against Lethal Influenza Infection

Cloutier, A., Marois, I., Cloutier, D., Verreault, C., Cantin, A. M., & Richter, M. V. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir804 · Cited by 64 · see citing works

Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development

Ahluwalia, K., Ebright, B., Chow, K. V., Dave, P., Mead, A., Poblete, R. A., Louie, S. G., & Asante, I. (2022) · Metabolites · doi:10.3390/metabo12040333 · Cited by 55 · see citing works

Inflammatory and oxidative stress in rotavirus infection

Guerrero, C., & Acosta, O. (2016) · World Journal of Virology · doi:10.5501/wjv.v5.i2.38 · Cited by 56 · see citing works

A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study

Suter, F., Consolaro, E., Pedroni, S., Moroni, C., Pastò, E., Paganini, M. V., Pravettoni, G., Cantarelli, U., Rubis, N., Perico, N., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100941 · Cited by 46 · see citing works

Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro

Lee, S. M.-Y., Gai, W., Cheung, T., & Peiris, M. J. S. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.07.011 · Cited by 46 · see citing works

Anti-Influenza Virus Activity of Tricin, 4′,5,7-trihydroxy-3′,5′-dimethoxyflavone

Yazawa, K., Kurokawa, M., Obuchi, M., Li, Y., Yamada, R., Sadanari, H., Matsubara, K., Watanabe, K., Koketsu, M., Tuchida, Y., et al. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1782 · Cited by 45 · see citing works

Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy

Littauer, E. Q., & Skountzou, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02455 · Cited by 43 · see citing works

Eicosanoids and Respiratory Viral Infection: Coordinators of Inflammation and Potential Therapeutic Targets

McCarthy, M. K., & Weinberg, J. B. (2012) · Mediators of Inflammation · doi:10.1155/2012/236345 · Cited by 43 · see citing works

Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings

Li, J., Jie, X., Liang, X., Chen, Z., Xie, P., 潘锡平, Zhou, B., & Li, J. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02918-3 · Cited by 37 · see citing works

Adjunctive therapies and immunomodulating agents for severe influenza

Hui, D. S. C., & Lee, N. L. S. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12171 · Cited by 37 · see citing works

The role of influenza A virus-induced hypercytokinemia

Wei, F., Gao, C., & Wang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1960482 · Cited by 34 · see citing works

Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation

Gopalakrishnan, A., Joseph, J., Shirey, K. A., Keegan, A. D., Boukhvalova, M. S., Vogel, S. N., & Blanco, J. C. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968336 · Cited by 33 · see citing works

sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae

Li, H., Bradbury, J. A., Edin, M. L., Graves, J. P., Gruzdev, A., Cheng, J., Hoopes, S. L., DeGraff, L. M., Fessler, M. B., Garantziotis, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci129679 · Cited by 31 · see citing works

TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice

Woods, P. S., Tazi, M., Chesarino, N. M., Amer, A. O., & Davis, I. C. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00078.2015 · Cited by 30 · see citing works

Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability

Dudek, S. E., Nitzsche, K., Ludwig, S., & Ehrhardt, C. (2016) · Scientific Reports · doi:10.1038/srep27275 · Cited by 30 · see citing works

How to approach and treat viral infections in ICU patients

Kelesidis, T., Mastoris, I., Metsini, A., & Tsiodras, S. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-321 · Cited by 28 · see citing works

A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)

Consolaro, E., Suter, F., Rubis, N., Pedroni, S., Moroni, C., Pastò, E., Paganini, M. V., Pravettoni, G., Cantarelli, U., Perico, N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.785785 · Cited by 26 · see citing works

Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Induces Prostaglandin E 2 Production through Cyclooxygenase 1, Which Is Dependent on the ERK1/2-p-C/EBP-β Pathway

Bi, Y., Guo, X.-K., Zhao, H., Gao, L., Wang, L., Tang, J., & Feng, W.-H. (2013) · Journal of Virology · doi:10.1128/jvi.03205-13 · Cited by 24 · see citing works

Emerging antiviral therapies and drugs for the treatment of influenza

Wang, J., Sun, Y., & Liu, S. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2149734 · Cited by 20 · see citing works

Prostaglandin E2 Induction during Mouse Adenovirus Type 1 Respiratory Infection Regulates Inflammatory Mediator Generation but Does Not Affect Viral Pathogenesis

McCarthy, M. K., Levine, R. E., Procario, M. C., McDonnell, P. J., Zhu, L., Mancuso, P., Crofford, L. J., Aronoff, D. M., & Weinberg, J. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077628 · Cited by 19 · see citing works

Antiviral Effects of Inhibiting Host Gene Expression

Tripp, R. A., & Tompkins, M. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_409 · Cited by 19 · see citing works

The pharmacological management of severe influenza infection – ‘existing and emerging therapies’

McMahon, A., & Martín‐Loeches, I. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1255550 · Cited by 18 · see citing works

Antiviral Resistance of Splenocytes in Aged Mice

Zaczyńska, E., Artym, J., Kocięba, M., Burster, T., Kruzel, M. L., Paprocka, M., & Zimecki, M. (2017) · Polish Journal of Microbiology · doi:10.5604/17331331.1235227 · Cited by 17 · see citing works

A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection

Yu, Y., Chen, S., Zhang, H., Duan, Y., Li, Z., Jiang, L., Cao, W., Peng, Q., & Chen, X. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01350-23 · Cited by 15 · see citing works

Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents

Almulhim, M. F., Ghasemian, A., Memariani, M., Karami, F., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11131-8 · Cited by 14 · see citing works

Host Immunomodulatory Interventions in Severe Influenza

Hui, D. S. C., & Chan, K. P. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf328 · Cited by 13 · see citing works

Influence of obesity on the response to influenza infection and vaccination

Karlsson, E. A., Milner, J. J., Green, W. D., Rebeles, J., Schultz‐Cherry, S., & Beck, M. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813553-2.00010-5 · Cited by 13 · see citing works

(+)‑pinoresinol‑O‑β‑D‑glucopyranoside from Eucommia�ulmoides Oliver and its anti‑inflammatory and antiviral effects against influenza�A (H1N1) virus infection

Li, J., Liang, X., Zhou, B., Chen, X., Xie, P., Jiang, H., Jiang, Z., Yang, Z., & Pan, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9696 · Cited by 13 · see citing works

Feline calicivirus- and murine norovirus-induced COX-2/PGE2 signaling pathway has proviral effects

Alfajaro, M. M., Cho, E.-H., Park, J., Kim, J., Soliman, M., Baek, Y., Kang, M.-I., Park, S., & Cho, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200726 · Cited by 12 · see citing works

Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?

Zhao, D. Y., Zhang, S., Igawa, T., & Frishman, W. H. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000340 · Cited by 12 · see citing works

Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties

Ferrucci, V., Miceli, M., Pagliuca, C., Bianco, O., Castaldo, L., Izzo, L., Cozzolino, M., Zannella, C., Oglio, F., Polcaro, A., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05378-2 · Cited by 10 · see citing works

Targeting eicosanoid pathways in the development of novel anti-influenza drugs

Coulombe, F., & Divangahi, M. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.966082 · Cited by 10 · see citing works

Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means

Terrier, O., & Slama‐Schwok, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_8 · Cited by 10 · see citing works

Regulation of inducible heme oxygenase and cyclooxygenase isozymes in a mouse model of spotted fever group rickettsiosis

Rydkina, E. B., Turpin, L. C., Sahni, A., & Sahni, S. (2012) · Microbial Pathogenesis · doi:10.1016/j.micpath.2012.03.010 · Cited by 9 · see citing works

Mucosal epithelial cells and novel approaches to immunoprophylaxy and immunotherapy of infectious diseases

Pinegin, B. V., Pashenkov, M. V., Pinegin, V. B., & Khaitov, R. M. (2020) · Immunologiya · doi:10.33029/0206-4952-2020-41-6-486-500 · Cited by 9 · see citing works

Mimicking Gene–Environment Interaction of Higher Altitude Dwellers by Intermittent Hypoxia Training: COVID-19 Preventive Strategies

Supriya, R., Singh, K. P., Gao, Y., Tao, D., Cheour, S., Dutheil, F., & Baker, J. S. (2022) · Biology · doi:10.3390/biology12010006 · Cited by 8 · see citing works

A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophrenia

Wang, P., Guan, X., Su, X., Wu, F., & Xiu, M. (2023) · Schizophrenia · doi:10.1038/s41537-023-00386-5 · Cited by 7 · see citing works

Cytokines and Viral Hemorrhagic Fever: Potential for Therapeutic Intervention

Findlay, J. S., Ulaeto, D., & D’Elia, R. V. (2015) · Future Virology · doi:10.2217/fvl.15.5 · Cited by 6 · see citing works

Chronic Exposure to the Food Additive tBHQ Modulates Expression of Genes Related to SARS-CoV-2 and Influenza Viruses

Németh, K., Petschner, P., Pálóczi, K., Fekete, N., Pállinger, É., Buzás, E. I., & Tamási, V. (2022) · Life · doi:10.3390/life12050642 · Cited by 4 · see citing works

Exploring Drug Repurposing for Influenza A (H3N2) Virus: A Computational Approach to Identifying Commercialized Drugs Targeting Hemagglutinin, Neuraminidase, and Nucleoprotein

Mounadi, N., Nour, H., Abass, K. S., Kouali, M. E., & Chtita, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00992 · Cited by 4 · see citing works

Proteomics of Bronchoalveolar Lavage Fluid Reveals a Lung Oxidative Stress Response in Murine Herpesvirus-68 Infection

Bortz, E., Wu, T.-T., Patel, P. H., Whitelegge, J. P., & Sun, R. (2018) · Viruses · doi:10.3390/v10120670 · Cited by 4 · see citing works

Musculoskeletal manifectations of the new coronavirus infection: focus on arthralgia and myalgia

Shostak, N. A., Клименко, А. А., Александровна, Д. Н., Александрович, К. А., Andriyashkina, D. Y., Saakyan, Y. M., Varaksin, G. A., & Tarantina, A. Y. (2022) · The Clinician · doi:10.17650/1818-8338-2021-15-1-4-k650 · Cited by 4 · see citing works

COVID‐19 and varicocele: The possible overlap factors and the common therapeutic approaches

Mahdavinezhad, F., Farmani, A. R., Pakniat, H., Taghavi, S., Gharaei, R., Valipour, J., & Amidi, F. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13518 · Cited by 4 · see citing works

Interplay between the arachidonic acid/cyclooxygenase 2/prostaglandin E 2 pathway and RNA viral infections

Navarro, A. J., Pastén-Ferrada, I. A., Cancino, F. A., Peñaloza, H. F., Kalergis, A. M., Carreño, L. J., & González, P. A. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2665216 · Cited by 3 · see citing works

INFLUENCE ON CELLULAR TARGETS FOR TREATING INFLUENZA INFECTION

Zarubaev, V. V., & Смирнов, В. С. (2014) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2014-1-15-26 · Cited by 2 · see citing works

Influenza virus-host interactions and their modulation by small molecules

Denisova, O. V. (2014) · Työväentutkimus Vuosikirja

Investigation of Inhaled Nitric Oxide and Mesenchymal Stromal Cells as Novel Therapeutic Strategies to Improve Clinical Outcome in Experimental Severe Influenza

Darwish, I. (2012) · TSpace (University of Toronto)

Antiviral agents for influenza virus

Perwitasari, O., Tripp, R. A., & Tompkins, S. M. (2015) · doi:10.2217/fmeb2013.14.45

Assessment of Bioaerosol Samplers for the Detection and Quantification of Influenza Virus and Compounds that Potentially Influence Influenza Virus Replication

Bekking, C. (2018) · TSpace (University of Toronto)

COVID-19 pathology and therapeuticsPreprint

El-Menshawy, H., & Sorour, K. (2020) · doi:10.14293/s2199-1006.1.sor-.pp1svrr.v1

COVID-19 pathology and therapeuticsPreprint

Sorour, K., & El-Menshawy, H. (2020) · doi:10.31730/osf.io/zc5em

The role of cytokine response in influenza virus pathogenesis in humans

Gouri, V., Singh, S. R., Khan, A., Sharma, A., & Samant, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15283-2.00013-0

Additional file 1 of Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings

Li, J., Jie, X., Liang, X., Chen, Z., Xie, P., 潘锡平, Zhou, B., & Li, J. (2020) · Figshare · doi:10.6084/m9.figshare.12258008

Timing-specific efficacy of antiviral baloxavir and anti-inflammatory oclacitinib monotherapies, and the benefits of their combination in treating influenza in mice

Yu, Y., Jiang, L., Ke, J., Lian, X., Gao, Y., Zhu, X., Zhang, M., Wu, H., & Chen, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1741128

Secondary analysis of influenza a virus-infected cells at single-cell resolution reveals host BANF1 response to individual and combinations of detected segments

Fears, Z., Berges, B. K., Manandhar, M., Tan, G. S., & Pickett, B. E. (2026) · Virology Journal · doi:10.1186/s12985-026-03140-2

The signaling adaptor insulin receptor substrate 2 (IRS2) limits lethal host responses induced by influenza infection

Prantner, D., Qi, X., Villaneuva, L. M., Paton, J., Blanco, J. C. G., Vogel, S. N., Keegan, A. D., & Shirey, K. A. (2026) · Innate Immunity · doi:10.1177/17534259261469305

Influenza A Viral Infection in Mice

Carey, M. A., Bradbury, J. A., Rebolloso, Y. D., Graves, J. P., Zeldin, D. C., & Dori, R. (2013)

Studies in the Cyperaceae; XXX, Carices aeorastachyae; Cryptocarpae nob.

Holm, T. (1920) · American Journal of Science · doi:10.2475/ajs.s4-50.296.159

Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection

Carey, M. A., Bradbury, J. A., Seubert, J. M., Langenbach, R. J., Zeldin, D. C., & Germolec, D. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6878 · Cited by 121 · see citing works

Regulierung der Expression von COX-2 nach Infektion mit Influenza-A-Viren

Nitzsche, K. (2014)

CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection

Tavares, L. P., Garcia, C. C., Machado, M. G., Queiroz‐Junior, C. M., Barthélémy, A., Trottein, F., Siqueira, M. M., Brandolini, L., Allegretti, M., Machado, A. V., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01799 · Cited by 66 · see citing works